[1] |
陈玲玲, 路丹丹, 施辛, 等. 肿瘤坏死因子α拮抗剂治疗一例伴嗜酸性粒细胞增多和系统症状药疹的临床观察[J]. 中华皮肤科杂志, 2013,46(9):621⁃625.
|
[2] |
中国医师协会皮肤科医师分会变态反应性疾病专业委员会. 药物超敏反应综合征诊治专家共识[J]. 中华皮肤科杂志, 2018,51(11):787⁃790. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 11.002.
|
[3] |
Al⁃Salama ZT. Apalutamide: first global approval[J]. Drugs, 2018,78(6):699⁃705. doi: 10.1007/s40265⁃018⁃0900⁃z.
|
[4] |
Perez⁃Ruixo C, Ackaert O, Ouellet D, et al. Efficacy and safety exposure⁃response relationships of apalutamide in patients with nonmetastatic castration⁃resistant prostate cancer[J]. Clin Cancer Res, 2020,26(17):4460⁃4467. doi: 10.1158/1078⁃0432.CCR⁃20⁃1041.
|
[5] |
Kardaun SH, Sidoroff A, Valeyrie⁃Allanore L, et al. Variability in the clinical pattern of cutaneous side⁃effects of drugs with systemic symptoms: does a DRESS syndrome really exist?[J]. Br J Dermatol, 2007,156(3):609⁃611. doi: 10.1111/j.1365⁃2133. 2006.07704.x.
|
[6] |
Shiohara T, Iijima M, Ikezawa Z, et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations[J]. Br J Dermatol, 2007,156(5):1083⁃1084. doi: 10.1111/j.1365⁃2133.2007.07807.x.
|
[7] |
Ducharme O, Sanchez⁃Pena P, Pham⁃Ledard A, et al. The first case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by apalutamide, a novel oral androgen receptor antagonist[J]. Contact Dermatitis, 2022,86(4):313⁃315. doi: 10.1111/cod.14024.
|
[8] |
Endo Y, Oka A, Uehara A, et al. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug[J]. J Dermatol, 2020,47(10):e359⁃e360. doi: 10.1111/1346⁃8138.15510.
|
[9] |
Miyagawa A, Adachi T, Kobayashi Y, et al. Plasmapheresis as a promising treatment option in apalutamide⁃associated toxic epidermal necrolysis[J]. J Dermatol, 2022,49(3):e102⁃e103. doi: 10.1111/1346⁃8138.16248.
|
[10] |
Osawa K, Kiniwa Y, Shimosato Y, et al. Toxic epidermal necrolysis caused by apalutamide: a case report of treatment using etanercept with conventional steroid therapy[J]. Acta Derm Venereol, 2022,102:adv00723. doi: 10.2340/actadv.v102.2243.
|
[11] |
Honda T, Tohi Y, Kaku Y, et al. Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer[J]. IJU Case Rep, 2022,5(6):497⁃500. doi: 10. 1002/iju5.12525.
|
[12] |
经晶, 路丹丹, 施辛, 等. 肿瘤坏死因子α拮抗剂治疗Stevens⁃Johnson综合征17例[J]. 中华皮肤科杂志, 2016,49(7):465⁃468.doi: 10.3760/cma.j.issn.0412⁃4030.2016.07.004.
|